Trial Search Results

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe that pulmonary hypertension in children is different than pulmonary hypertension in adults and this study will help us understand those differences.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

University of Colorado, Denver

Collaborator: National Heart, Lung, and Blood Institute (NHLBI)


Inclusion Criteria:

   - The subject's age of onset of pulmonary hypertension must be prior to age 18 years

   - The person providing consent must be able to read either Spanish or English.

   - The subject (and/or parent/legal guardian) must be able to provide informed consent

Exclusion Criteria:

   - Diagnosed with pulmonary hypertension after age 18

   - Refusal to sign informed consent

Ages Eligible for Study

N/A - 21 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jeffrey Feinstein, MD